SATSUMA PHARMACEUTICALS INC's ticker is STSA and the CUSIP is 80405P107.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $642,981 | -22.4% | 920,517 | 0.0% | 0.00% | – |
| Q4 2022 | $828,465 | -84.8% | 920,517 | +1.2% | 0.00% | – |
| Q3 2022 | $5,457,000 | +105.8% | 909,390 | +42.0% | 0.00% | – |
| Q2 2022 | $2,651,000 | +7.6% | 640,364 | -1.2% | 0.00% | – |
| Q1 2022 | $2,463,000 | -16.4% | 648,332 | -1.0% | 0.00% | – |
| Q4 2021 | $2,946,000 | -2.2% | 654,846 | +1.3% | 0.00% | – |
| Q3 2021 | $3,013,000 | -33.7% | 646,513 | +0.3% | 0.00% | – |
| Q2 2021 | $4,542,000 | +263.4% | 644,301 | +204.5% | 0.00% | – |
| Q1 2021 | $1,250,000 | +43.7% | 211,560 | +12.1% | 0.00% | – |
| Q4 2020 | $870,000 | +5.6% | 188,808 | -10.8% | 0.00% | – |
| Q3 2020 | $824,000 | -92.6% | 211,735 | -45.5% | 0.00% | – |
| Q2 2020 | $11,179,000 | +93.7% | 388,700 | +45.0% | 0.00% | – |
| Q1 2020 | $5,771,000 | -3.2% | 268,153 | -11.4% | 0.00% | – |
| Q4 2019 | $5,959,000 | +1032.9% | 302,793 | +765.1% | 0.00% | – |
| Q3 2019 | $526,000 | – | 35,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 870,820 | $13,071,000 | 14.74% |
| RA Capital Management | 4,681,858 | $70,275,000 | 4.19% |
| Cormorant Asset Management, LP | 858,382 | $12,884,000 | 0.78% |
| Monashee Investment Management LLC | 62,500 | $938,000 | 0.43% |
| TPG Group Holdings (SBS) Advisors, Inc. | 3,771,878 | $56,616,000 | 0.42% |
| DC Investments Management, LLC | 35,502 | $533,000 | 0.31% |
| Eventide Asset Management | 425,000 | $6,379,000 | 0.21% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 610,000 | $9,156,000 | 0.02% |
| Weiss Asset Management LP | 14,150 | $212,000 | 0.02% |
| Zimmer Partners, LP | 100,000 | $1,501,000 | 0.02% |